Bradley Jones
Physician Assistant · Southfield, MINPI 1285848283
Payments from drug & device makers
Across 46 payments — averaging $24.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$195
- Pfizer$157
- Bristol Myers Squibb$88
- Teva Pharmaceuticals USA, Inc.$81
- Nevro Corp.$68
- EMD Serono, Inc.$64
- plus $454 from 16 others
What the payments were for
- Food & beverage$1,02693%
- Education$817%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 9 | $195 |
| Pfizer | 9 | $157 |
| Bristol Myers Squibb | 5 | $88 |
| Teva Pharmaceuticals USA, Inc. | 1 | $81 |
| Nevro Corp. | 1 | $68 |
| EMD Serono, Inc. | 2 | $64 |
| ANI Pharmaceuticals, Inc. | 2 | $50 |
| Lilly USA, LLC | 3 | $50 |
| Vanda Pharmaceuticals Inc. | 1 | $36 |
| TG Therapeutics, Inc. | 1 | $35 |
| CSL Behring | 1 | $31 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $30 |
| Sanofi | 1 | $27 |
| Lundbeck LLC | 1 | $27 |
| Novo Nordisk | 1 | $26 |
| UCB, Inc. | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| Boston Scientific | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| Acadia Pharmaceuticals Inc | 1 | $18 |
| Neurelis, Inc. | 1 | $14 |
How this compares
$1,107 in reported general payments places this provider in the 75th percentile of 5,453 physician assistant providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Avonex Pen (4 Pack)Interferon Beta-1a | 42 | $334,592 |
| OxycontinOxycodone Hcl | 302 | $205,908 |
| TecfideraDimethyl Fumarate | 12 | $110,165 |
| ZeposiaOzanimod Hydrochloride | 12 | $104,545 |
| Oxymorphone Hcl ErOxymorphone Hcl | 48 | $39,598 |
| Diclofenac Sodium | 86 | $38,896 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,866 | $36,164 |
| UbrelvyUbrogepant | 27 | $27,757 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,308 | $25,961 |
| Nurtec OdtRimegepant Sulfate | 21 | $25,071 |
| Xtampza ErOxycodone Myristate | 41 | $22,644 |
| Aimovig AutoinjectorErenumab-Aooe | 21 | $20,098 |
| Morphine Sulfate ErMorphine Sulfate | 535 | $14,099 |
| Gabapentin | 986 | $12,901 |
| Tizanidine Hcl | 414 | $11,567 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy | $195 | $27,75727 claims |
| PfizerNurtec Odt | $157 | $25,07121 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 5,453 physician assistant providers in Michigan.
Other physician assistant in Southfield
- Sarang PatelRoyal Oak$660K
- Beth SweneyAda$617K
- Zainab JishiCanton$596K
- Taylor HennrickAdrian$430K
- Erin van DykeGrand Rapids$346K
- Ashley AldridgeAnn Arbor$298K
- Derek SusallaRochester Hills$242K
- Gabrielle DamoreRoyal Oak$200K
- Melissa MickelsonKalamazoo$168K
- Patrick CooneyNew Baltimore$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.